Testing the Addition of an Anti-cancer Drug, Ipatasertib, to the Usual Immunotherapy Treatment (Pembrolizumab) in Patients With Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck

Key facts

Sponsor

National Cancer Institute (NCI)

Principal Investigator

Jacob S Thomas

City of Hope Comprehensive Cancer Center LAO

Intervention

Biopsy Procedure(procedure)

Enrollment

52 enrolled

Eligibility

18 years · All sexes

Timeline

2022 – 2027

Study locations (20)

• City of Hope Comprehensive Cancer Center, Duarte, California, United States
• City of Hope at Irvine Lennar, Irvine, California, United States
• City of Hope Antelope Valley, Lancaster, California, United States
• Keck Medicine of USC Koreatown, Los Angeles, California, United States
• Los Angeles General Medical Center, Los Angeles, California, United States
• USC / Norris Comprehensive Cancer Center, Los Angeles, California, United States
• USC Norris Oncology/Hematology-Newport Beach, Newport Beach, California, United States
• Stanford Cancer Institute Palo Alto, Palo Alto, California, United States
• University of California Davis Comprehensive Cancer Center, Sacramento, California, United States
• MedStar Georgetown University Hospital, Washington D.C., District of Columbia, United States
• Northwestern University, Chicago, Illinois, United States
• University of Kentucky/Markey Cancer Center, Lexington, Kentucky, United States
• NYU Langone Hospital - Long Island, Mineola, New York, United States
• Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York, New York, United States
• NYP/Weill Cornell Medical Center, New York, New York, United States
• +5 more locations on ClinicalTrials.gov

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Squamous cell carcinoma of oral cavity and lip

Additional recruiting or active studies for the same condition.

• RECRUITINGPHASE2NCT07195734
  Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer
  National Cancer Institute (NCI)
• RECRUITINGNANCT07264036
  Velopharyngeal Dysfunction in Head & Neck Cancer Patients, Pilot Study
  Vanessa Torrecillas
• RECRUITINGPHASE2NCT07121595
  Personalized Neck Radiation Therapy Directed by Sentinel Lymph Node Biopsy for the Treatment of Oral Cavity Squamous Cell Carcinoma, PRECEDENT Trial
  University of Michigan Rogel Cancer Center
• RECRUITINGNCT05837221
  Microbiome in Head and Neck Squamous Cell Carcinoma
  University of Colorado, Denver
• RECRUITINGPHASE2NCT05576974
  A Phase 2a, Single-dose, Open-label Study to Evaluate Diagnostic Performance and Safety of Pegsitacianine, an Intraoperative Fluorescence Imaging Agent for the Detection of Cancer, in Patients With Unknown Primary Head and Neck Cancer (ILLUMINATE STUDY)
  University of Texas Southwestern Medical Center
• RECRUITINGPHASE1, PHASE2NCT06265025
  GM103 Intratumoral Injection in Patients With Locally Advanced, Unresectable, Refractory and/or Metastatic Solid Tumors
  GeneMedicine Co., Ltd.
• RECRUITINGNANCT05811936
  The SNAP Tool for Head and Neck Cancer Survivor-Caregiver Dyads
  Medical University of South Carolina
• ACTIVE NOT RECRUITINGPHASE1NCT05820711
  Study Transplanting Bone Marrow Cells Into Salivary Glands to Treat Dry Mouth Caused by Radiation Therapy
  University of Wisconsin, Madison

See all trials for Squamous cell carcinoma of oral cavity and lip →